Comparative Studies on the Anticoagulant Profile of Branded Enoxaparin and a New Biosimilar Version

Low molecular weight heparins (LMWH) represent depolymerized heparin prepared by various methods that exhibit differential, biochemical and pharmacological profiles. Enoxaparin is prepared by benzylation followed by alkaline depolymerization of porcine heparin. Upon the expiration of its patent, sev...

Full description

Bibliographic Details
Main Authors:	Dalia Qneibi MD, Eduardo Ramacciotti MD, PhD, Ariane Scarlatelli Macedo MD, Roberto Augusto Caffaro MD, PhD, Leandro Barile Agati PhD, Fakiha Siddiqui BDS, Ahmed Kouta MS, Debra Hoppensteadt PhD, Jawed Fareed PhD, Charles A. Carter PharmD, MBA, BS
Format:	Article
Language:	English
Published:	SAGE Publishing 2020-09-01
Series:	Clinical and Applied Thrombosis/Hemostasis
Online Access:	https://doi.org/10.1177/1076029620960820

Similar Items

Differential Neutralization of Unfractionated Heparin and Enoxaparin by Andexanet Alfa
by: Joseph Lewis BA, et al.
Published: (2022-05-01)

Assay-Based Differentiation in the Neutralization Profile of Unfractionated Heparin, Enoxaparin, and Fondaparinux by Andexanet Alfa
by: Fakiha Siddiqui BDS, et al.
Published: (2020-01-01)

Factor Xa Inhibitory Profile of Apixaban, Betrixaban, Edoxaban, and Rivaroxaban Does Not Fully Reflect Their Biologic Spectrum
by: Fakiha Siddiqui BDS, et al.
Published: (2019-05-01)

Comparative Anticoagulant and Thrombin Generation Inhibitory Profile of Heparin, Sulodexide and Its Components
by: Fakiha Siddiqui BDS, et al.
Published: (2020-10-01)

Rivaroxaban Versus Enoxaparin for Thromboprophylaxis After major Gynecological Cancer Surgery: The VALERIA Trial
by: André Luiz Malavasi Longo de Oliveira MD, MSc, et al.
Published: (2022-12-01)

Comparison of Low-Molecular-Weight Heparins Prepared From Ovine Heparins With Enoxaparin
by: Jianle Chen BS, et al.
Published: (2019-04-01)

Potency Adjusted Blended Heparin of Bovine, Ovine, and Porcine Heparin Exhibit Comparable Biologic Effects to Referenced Single-Sourced Porcine Heparin
by: Guy Olson BS, et al.
Published: (2023-03-01)

Endogenous Glycosaminoglycans in Various Pathologic Plasma Samples as Measured by a Fluorescent Quenching Method
by: Bulent Kantarcioglu MD, et al.
Published: (2022-12-01)

Thrombin Generation Profile in Various Lymphoma Sub-Groups and Its Augmentation by Andexanet Alfa
by: Fakiha Siddiqui BDS, et al.
Published: (2020-12-01)

Development of an Algorithm to Predict Mortality in Patients With Sepsis and Coagulopathy
by: Amanda Walborn PhD, et al.
Published: (2020-03-01)

The Relevance of Anti-PF4 Antibody Isotypes and Endogenous Glycosaminoglycans and their Relationship with Inflammatory Biomarkers in Pulmonary Embolism Patients
by: Bulent Kantarcioglu MD, et al.
Published: (2022-04-01)

Is the Reason of Increased D-Dimer Levels in COVID-19 Because of ACE-2-Induced Apoptosis in Endothelium?
by: Nil Guler MD, et al.
Published: (2020-07-01)

The Relevance of Thrombo-Inflammatory Biomarkers and Their Relationship with Circulating Glycosaminoglycans in End-Stage Renal Disease Patients
by: Madeline Allen BS, et al.
Published: (2023-04-01)

Direct Oral Anticoagulants and Cancer-Associated Thrombosis Management. Where Do We Stand in 2019?
by: Eduardo Ramacciotti MD, PhD, et al.
Published: (2019-06-01)

Porcine Mucosal Heparin Shortage Crisis! What Are the Options?
by: Jawed Fareed PhD, et al.
Published: (2019-09-01)

Endothelial Dysfunction Is Associated with Mortality and Severity of Coagulopathy in Patients with Sepsis and Disseminated Intravascular Coagulation
by: Amanda Walborn PhD, et al.
Published: (2019-05-01)

Biomarkers of Platelet Activation and Their Prognostic Value in Patients With Sepsis-Associated Disseminated Intravascular Coagulopathy
by: Gracelene Wegrzyn MD, et al.
Published: (2021-02-01)

Glycemic Control and Plasma Levels of Pro-Inflammatory and Pro-Thrombotic Biomarkers in Diabetic Patients Presenting with Acute Pulmonary Embolism
by: Alexander O’Hara BS, et al.
Published: (2023-03-01)

Markers of Inflammation and Infection in Sepsis and Disseminated Intravascular Coagulation
by: Priya Patel BS, et al.
Published: (2019-04-01)

Comparative Pharmacological Profiles of Various Bovine, Ovine, and Porcine Heparins
by: Ahmed Kouta MS, MBA, et al.
Published: (2019-11-01)

Update on the safety and bioequivalence of biosimilars – focus on enoxaparin
by: Jeske W, et al.
Published: (2013-06-01)

Viral Coagulopathy in Patients With COVID-19: Treatment and Care
by: Nickolas Kipshidze MD, PhD, DSc, et al.
Published: (2020-07-01)

Predictive Role of Blood Cellular Indices and Their Relationship with Endogenous Glycosaminoglycans as Determinants of Inflammatory Biomarkers in Pulmonary Embolism
by: Bulent Kantarcioglu MD, et al.
Published: (2022-06-01)

Interrelationship Between Inflammatory Biomarkers and Collagen Remodeling Proteins in Atrial Fibrillation
by: Ameer Odeh BS, et al.
Published: (2023-03-01)

Collagen Remodeling and Fatty Acid Regulation Biomarkers in Understanding the Molecular Pathogenesis of Atrial Fibrillation
by: Ameer Odeh BS, et al.
Published: (2022-12-01)

Targeted, Site-Specific, Delivery Vehicles of Therapeutics for COVID-19 Patients. Brief Review
by: Nicholas Kipshidze MD, PhD, DSc, et al.
Published: (2020-09-01)

Interrelationship of MMP-9, Proteoglycan-4, and Inflammation in Osteoarthritis Patients Undergoing Total Hip Arthroplasty
by: Hannah Slovacek BS, et al.
Published: (2021-03-01)

The Role of IL-13, IL-15 and Granulysin in the Pathogenesis of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis
by: Michael Sadek MD, et al.
Published: (2021-02-01)

Evidence-Based Practical Guidance for the Antithrombotic Management in Patients With Coronavirus Disease (COVID-19) in 2020
by: Eduardo Ramacciotti MD, PhD, et al.
Published: (2020-07-01)

Osteopontin Levels in Patients With Chronic Kidney Disease Stage 5 on Hemodialysis Directly Correlate With Intact Parathyroid Hormone and Alkaline Phosphatase
by: Aleksander Druck BS, et al.
Published: (2019-12-01)

Differential Neutralization of Apixaban, Betrixaban, Edoxaban, and Rivaroxaban by Andexanet Alfa as Measured by Whole Blood Thromboelastographic Analysis
by: Siddharth Mehrotra, et al.
Published: (2022-12-01)

The Relationship Between Thrombo-Inflammatory Biomarkers and Cellular Indices of Inflammation in Lymphoma Patients
by: Mark Jaradeh BS, et al.
Published: (2021-10-01)

Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios Predict All-Cause Mortality in Acute Pulmonary Embolism
by: Trung Phan MD, et al.
Published: (2020-01-01)

Zika and Chikungunya Virus and Risk for Venous Thromboembolism
by: Eduardo Ramacciotti MD, PhD, et al.
Published: (2019-01-01)

Acquired Exon 14 MET Mutation Associated With Resistance to Alectinib in a Patient With ALK–Rearranged NSCLC
by: Catherine Daniel, MD, PhD, et al.
Published: (2020-11-01)

Drug-induced hypersensitivity reactions in a Lebanese outpatient population: A decade-long retrospective analysis (2012-2021)
by: Joelle Dagher, PharmD, PhD, et al.
Published: (2024-02-01)

Studies on Tissue Factor Pathway Inhibitor Antigen Release by Bovine, Ovine and Porcine Heparins Following Intravenous Administration to Non-Human Primates
by: Ahmed Kouta MS, MBA, et al.
Published: (2020-10-01)

Protamine Sulfate Neutralization Profile of Various Dosages of Bovine, Ovine and Porcine UFHs and Their Depolymerized Derivatives in Non-Human Primates
by: Ahmed Kouta MS, MBA, et al.
Published: (2021-04-01)

Revascularization of Peripheral Arteries in Patients with Intermittent Claudication Decreases Inflammatory Biomarkers
by: Pavel Poredoš MD, PhD, et al.
Published: (2023-06-01)

COVID-19: General Strategies for Herbal Therapies
by: Samaneh Soleymani PharmD, PhD, et al.
Published: (2022-01-01)